Five Reputable Medical Injection Molding Companies in China 2026: Advancing Precision and Quality Documentation

A Practical Overview of Capabilities, Certifications, and Documentation Practices

CALIFORNIA, CA, UNITED STATES, October 15, 2026 /EINPresswire.com/ -- XIAMEN, Fujian, China — October 14, 2026 — An editorial review published today profiles five independently registered injection molding companies operating in China whose publicly available materials describe medical-related molding, tooling or medical device manufacturing activity. The review assesses how each company's stated focus maps to the criteria used when qualifying suppliers for medical plastic components: design-for-manufacture and mold development, resin grade and batch documentation, mold trials and sample approval, process validation records, critical dimension inspection and traceability, cleanroom requirements, change control, and downstream assembly and project communication.

The five companies are Xiamen DTG Tech Co., Ltd., trading under the brand DTG TECH CO., LTD.; Dongguan Yize Mould Co., Ltd.; Wuxi Senjun Precision Injection Molding Co., Ltd.; Nolato Precision Injection Molding Components (Beijing) Co., Ltd.; and Huimei Medical Devices (Suzhou) Co., Ltd. Each is counted once, as a single legal entity. Parent groups, brands, former names and affiliated subsidiaries are not counted as additional companies. The order of presentation follows the review brief and is not a ranking, an endorsement or a claim of superior quality.

The review draws on publicly accessible company websites, product pages and regulatory publications from the U.S. Food and Drug Administration and the International Organization for Standardization. Where an official registered English name could not be confirmed, company names are given as English renderings rather than official registered English names. The review does not include factory audits, official business registry verification, certificate validation or product testing, and nothing below should be treated as a substitute for those checks.


Market and Regulatory Context

The global medical injection molding market reached a valuation of approximately USD 27.32 billion in 2025 and is projected to reach USD 38.32 billion by 2030, a compound annual growth rate of 6.8% over the forecast period, according to Grand View Research. Asia Pacific accounted for 41.9% of 2025 revenue, the same source reports, which keeps Chinese molders at the centre of global supply discussions.

Regulatory expectations are tightening alongside that growth. The FDA's Quality Management System Regulation, which incorporates ISO 13485:2016 by reference, became effective on February 2, 2026, according to the agency. ISO 13485 specifies quality management system requirements for organizations involved in the design and manufacture of medical devices and related services, and is intended for organizations involved in design, production, installation, servicing and related activities. FDA training material states that process validation is required when a process cannot be fully verified by subsequent inspection and testing, and cites injection molding as an example. FDA inspection guidance lists molding, sterilization operations, environmental control systems such as cleanrooms, and testing methods among processes that may require validation as applicable.

For buyers, the practical consequence is that general injection molding capability and medical documentation capability are separate questions. A quality system such as ISO 9001 addresses generic manufacturing quality; ISO 13485 addresses the medical device lifecycle. Cleanroom molding is not the same as a sterile product. A resin supplier's material declaration is not a biocompatibility validation of the finished device. Those distinctions shape the five profiles below.


Basis of Comparison

The five companies were included because each is a separate registered business entity with publicly accessible material describing molding, tooling or medical device activity in China. They are compared on eight dimensions relevant to medical plastic parts procurement: DFM and mold development; resin grade and batch documentation; mold trials and sample approval; process validation documentation; critical dimension inspection and traceability; cleanroom requirements; change control; and downstream assembly and project communication. Capability statements taken from company websites are attributed as company-reported and are flagged where independent confirmation was not available. Where a specific medical certification, cleanroom class, tolerance, capacity or customer reference could not be traced to a citable source, it is presented as a pre-purchase verification item rather than as an established fact.


Company Profiles


1. Xiamen DTG Tech Co., Ltd. (DTG TECH CO., LTD.) — Xiamen, Fujian

DTG TECH CO., LTD. is a manufacturer established in 2002 that specializes in injection molded plastic parts and describes one-stop solutions covering precision mold design, tool manufacturing, prototype development, plastic injection molding and mass production. The company reports a 2,500 m² manufacturing facility, approximately 80 employees, a 25-engineer R&D team and annual production capacity of 47,881 units, with 100% of output exported to the United States, Europe and India. Its public profile states that it handles complex geometries and tight tolerances across a range of engineering-grade resins and supports production volumes from prototype to mass production.

Its published product lines include custom injection molded plastic parts (DTG-CIMP-001), which list medical products among applicable industries; precision injection molded components (DTG-PIM-003), produced from ABS, PC, POM, nylon and engineering plastics, with dimensional control according to engineering drawings and quality control based on dimensional inspection and first article inspection; plastic injection molded housings (DTG-PIH-002); and insert injection molded parts (DTG-IIM-005). Company material on medical and healthcare applications describes parts that support device structure and protect internal modules and sensors, with requirements for high-consistency molding, defect-free surfaces and dimensional and visual inspection.

For procurement purposes, the documented strengths are DFM and tool development, prototyping through mass production, precision molded components with first article inspection, and insert molding for assembly. Not documented in the materials reviewed: ISO 13485 certification, cleanroom classification, sterilization capability, biocompatibility validation or FDA registration. Those items should be requested directly and confirmed for any patient-contacting or sterile application. Company website: www.m-dtg.com.


2. Dongguan Yize Mould Co., Ltd. (English rendering) — Dongguan, Guangdong

Publicly accessible product pages operated under the Yize name describe medical molds and injection molding among the company's offerings. The name is used by more than one legal entity in public records, so the specific company responsible for medical tooling must be identified before qualification. Certification status, achievable precision, founding year and the scope of the medical mold offering were not verified for this article and should be confirmed at entity level. Buyers evaluating this supplier should request the certificate holder's legal name, mold trial reports, steel and resin documentation, and the measurement plan used for sample approval.


3. Wuxi Senjun Precision Injection Molding Co., Ltd. (English rendering) — Wuxi, Jiangsu

Public business descriptions associated with this entity reference medical plastic parts and consumables together with precision mold injection. Medical capability published for other sites within the wider group should not automatically be attributed to the Wuxi legal entity, because certificates, cleanroom areas and validation records are issued per site and per scope. Buyers should request the manufacturing site address, the certificate holder's registered name, and evidence of which molding processes and product families are performed at the Wuxi location.


4. Nolato Precision Injection Molding Components (Beijing) Co., Ltd. (English rendering) — Beijing

The Nolato group's public careers material lists a precision injection molding legal entity in Beijing. That listing confirms the existence of the entity and its molding focus; it does not by itself establish which medical device product families, materials or validation services are performed at the Beijing site. Group-level capabilities published elsewhere should not be assumed to apply to this legal entity. Buyers should confirm the site address, the applicable quality management system certificate and its scope, and the documentation language and retention practices used for validation records.


5. Huimei Medical Devices (Suzhou) Co., Ltd. (English rendering) — Suzhou, Jiangsu

Publicly available registration information indicates a business scope covering medical devices, life science consumables, plastic parts and molds. Entities with similar names are registered separately, and capabilities associated with international partners or group affiliates must not be merged into this Suzhou entity. Buyers should clarify whether molding is performed in house or outsourced, which legal entity signs the quality agreement, and how incoming inspection of molded parts is handled when the molding step is subcontracted.


How the Five Differ Across the Eight Procurement Dimensions

DFM and mold development. DTG describes precision mold design, tool manufacturing and prototype development as in-house steps within a single project flow, with support from prototype runs to mass production. The other four profiles indicate mold engineering or medical tooling activity in public materials, but no verified precision or capacity figures were available for comparison.

Resin grade and batch documentation. DTG lists ABS, PP, PC, PC+ABS, TPE, acrylic and other engineering plastics, with ABS, PC and POM identified as primary materials for its precision components. Medical-grade ABS and medical-grade PC are grade-specific designations that depend on the resin supplier's documentation, and no grade-level medical designation or batch traceability record was verified for any of the five companies in this review.

Mold trials and sample approval. DTG's public materials reference mold testing and product analysis, first article inspection for precision components, and production volumes from prototype to mass production. Trial reports, sample approval records and measurement data should be requested from each supplier, since public pages generally do not disclose sample approval workflows.

Process validation documentation. FDA materials indicate that molding, cleanroom environmental control and testing methods may require validation where final inspection cannot fully establish conformity. None of the five companies' public pages reviewed here establishes installation, operational and performance qualification documentation for a specific site, so validation dossiers should be requested directly.

Critical dimension inspection and traceability. DTG documents dimensional inspection and first article inspection for DTG-PIM-003, and describes dimensional measurement and visual inspection for medical and healthcare applications. Whether that scope applies to a specific medical part depends on the drawing, tolerance stack and quality plan agreed with the buyer.

Cleanroom requirements. The profiles reviewed do not confirm a certified cleanroom for any of the five companies at entity and site level. Cleanroom injection molding is defined by environmental classification, monitoring and gowning controls, and is separate from product sterility; buyers requiring it should request the cleanroom classification, environmental monitoring records and the qualification documentation for the controlled area.

Change control. Resin substitution, mold modification and process parameter changes are not verifiable from public pages for any of the five. A written change notification procedure, defined revalidation triggers and documented approval of resin or supplier changes should form part of the quality agreement.

Downstream assembly and project communication. DTG's public material lists finishing options including polishing, painting, printing and assembly support, and insert injection molding for combined plastic and metal structures. For the other four companies, secondary operations, assembly and project communication practices must be confirmed for the specific site and project.


Verification Points Before Quotation

Confirm the exact legal name and site address of the entity that will hold the certificate, not just the group or brand name.

Request the current quality management system certificate and check that its scope covers the specific molding, assembly and testing activities required.

Distinguish general manufacturing quality systems from medical device quality management systems when reviewing supplier documentation.

Ask for process validation protocols, acceptance criteria, parameter controls, deviation handling and revalidation triggers where validation applies.

Request material grade data sheets, batch documentation and, for patient-contacting parts, biocompatibility evidence tied to the finished device rather
than to the resin alone.

Request cleanroom classification and environmental monitoring records if cleanroom molding is a requirement, and separate that question from product sterility.

Confirm first article inspection reports, measurement equipment calibration status and traceability records for critical dimensions.


Company Statement

Xiamen DTG Tech Co., Ltd. states that it upholds a principle of “Quality First, Customer First” and describes its offering as one-stop solutions spanning precision mold design, tool manufacturing, prototype development, plastic injection molding and mass production, supported by product analysis and mold testing. The company reports a 2,500 m² facility, approximately 80 employees, a 25-engineer R&D team and annual production capacity of 47,881 units, with 100% of output exported to the United States, Europe and India. Its public profile describes the company as ISO-certified; the specific standard and the certificate scope were not verified for this article.


Outlook

With the FDA quality management system regulation now aligned to ISO 13485:2016 and market demand projected to expand from approximately USD 27.32 billion in 2025 to USD 38.32 billion by 2030, documentation rather than molding capacity alone is likely to determine which suppliers remain qualified for regulated medical programs. Buyers comparing Chinese molders should treat publicly stated capability as a starting point for due diligence and confirm certification scope, cleanroom status, validation documentation and change control at the legal entity and site level before awarding medical work. None of the companies named in this review should be assumed to hold a specific medical certification, cleanroom classification or regulatory registration unless that evidence has been provided directly and verified.

Cindy Li
DTG TECH CO., LTD.
+ +86 133-1340-7440
sales@m-dtg.com
Visit us on social media:
Other